BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28641043)

  • 41. Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study.
    Alizzi Z; Gogbashian A; Karteris E; Hall M
    Cancer Imaging; 2023 Jun; 23(1):62. PubMed ID: 37322564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer.
    Kim KW; Choi HJ; Kang S; Park SY; Jung DC; Cho JY; Cho KS; Kim SH
    Eur J Radiol; 2010 Aug; 75(2):230-5. PubMed ID: 19481402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures.
    Winterhoff B; Hamidi H; Wang C; Kalli KR; Fridley BL; Dering J; Chen HW; Cliby WA; Wang HJ; Dowdy S; Gostout BS; Keeney GL; Goode EL; Konecny GE
    Gynecol Oncol; 2016 Apr; 141(1):95-100. PubMed ID: 27016234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
    Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
    Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study.
    Siewert B; Millo NZ; Sahi K; Sheiman RG; Brook OR; Sun MRM; Kane RA
    Radiology; 2018 Apr; 287(1):156-166. PubMed ID: 29369753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features.
    Woodard GA; Ray KM; Joe BN; Price ER
    Radiology; 2018 Jan; 286(1):60-70. PubMed ID: 28885890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic Accuracy of CT Enterography for Active Inflammatory Terminal Ileal Crohn Disease: Comparison of Full-Dose and Half-Dose Images Reconstructed with FBP and Half-Dose Images with SAFIRE.
    Gandhi NS; Baker ME; Goenka AH; Bullen JA; Obuchowski NA; Remer EM; Coppa CP; Einstein D; Feldman MK; Kanmaniraja D; Purysko AS; Vahdat N; Primak AN; Karim W; Herts BR
    Radiology; 2016 Aug; 280(2):436-45. PubMed ID: 27077382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters.
    Son HM; Kim SH; Kwon BR; Kim MJ; Kim CS; Cho SH
    Acta Radiol; 2017 Apr; 58(4):498-504. PubMed ID: 27439399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disseminated peritoneal tuberculosis simulating advanced ovarian cancer: a retrospective study of 17 cases.
    Wu CH; Changchien CC; Tseng CW; Chang HY; Ou YC; Lin H
    Taiwan J Obstet Gynecol; 2011 Sep; 50(3):292-6. PubMed ID: 22030041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.
    Lakhman Y; Yakar D; Goldman DA; Katz SS; Vargas HA; Miccò M; Zheng J; Moskowitz CS; Soslow RA; Hricak H; Abu-Rustum NR; Sala E
    Abdom Imaging; 2015 Aug; 40(6):1761-8. PubMed ID: 25549782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
    Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
    Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic CT findings of malignant bowel obstruction in patients with advanced ovarian cancer.
    Miccò M; Sbarra M; Gui B; Bianco NC; Rodolfino E; Manfredi R
    Tumori; 2020 Apr; 106(2):149-154. PubMed ID: 31739760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
    Kumar A; Wang C; Sheedy SP; McCauley BM; Winham SJ; Ramus SJ; Anglesio MS; Kim B; Torres D; Keeney GL; Cliby WA; Goode EL
    Gynecol Oncol; 2022 Sep; 166(3):508-514. PubMed ID: 35931468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
    Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis.
    Smith AD; Branch CR; Zand K; Subramony C; Zhang H; Thaggard K; Hosch R; Bryan J; Vasanji A; Griswold M; Zhang X
    Radiology; 2016 Sep; 280(3):771-81. PubMed ID: 27089026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
    Axtell AE; Lee MH; Bristow RE; Dowdy SC; Cliby WA; Raman S; Weaver JP; Gabbay M; Ngo M; Lentz S; Cass I; Li AJ; Karlan BY; Holschneider CH
    J Clin Oncol; 2007 Feb; 25(4):384-9. PubMed ID: 17264334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
    Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
    Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CT features of serous surface papillary carcinoma of the ovary.
    Kim HJ; Kim JK; Cho KS
    AJR Am J Roentgenol; 2004 Dec; 183(6):1721-4. PubMed ID: 15547217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.